Inari Medical, Inc. (NARI)

57.57 -1.10 (-1.87%) At close: 04:00PM EST

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 800

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Andrew J. Hykes	CEO, Pres & Director	750.84k	4.38M	1974
Mr. Mitchell C. Hill	Chief Financial Officer	687.42k	9.79M	1959
Dr. Thomas M. Tu M.D.	Chief Medical Officer	752.29k	8.05M	1973
Ms. Angela Ahmad	Gen. Counsel & Sec.	N/A	N/A	N/A
Mr. Eric Khairy	Sr. VP of Marketing	N/A	N/A	N/A
Mr. John R. Borrell	Sr. VP of Sales	N/A	N/A	1967
Ms. Tara Dunn	Sr. VP of Clinical Affairs & Market Devel.	N/A	N/A	N/A
Mr. Brian Strauss	Sr. VP of Engineering	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Corporate governance

Inari Medical, Inc.’s ISS governance QualityScore as of 28 January 2023 is 8. The pillar scores are Audit: 9; Board: 8; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.